Citation

Prime ME, Andersen OA, Barker JJ, Brooks MA, Cheng RK, Toogood-Johnson I, Courtney SM, Brookfield FA, Yarnold CJ, Marston RW, Johnson PD, Johnsen SF, Palfrey JJ, Vaidya D, Erfan S, Ichihara O, Felicetti B, Palan S, Pedret-Dunn A, Schaertl S, Sternberger I, Ebneth A, Scheel A, Winkler D, Toledo-Sherman L, Beconi M, Macdonald D, Muñoz-Sanjuan I, Dominguez C, Wityak J.: Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease. J Med Chem, Volume 55 (3), 2012

Authors

Andersen OA, Barker JJ, Beconi M, Brookfield FA, Brooks MA, Cheng RK, Courtney SM, Dominguez C, Ebneth A, Erfan S, Felicetti B, Ichihara O, Johnsen SF, Johnson PD, MacDonald D, Marston RW, Munoz-Sanjuan I, Palan S, Palfrey JJ, Pedret-Dunn A, Prime ME, Schaertl S, Scheel A, Sternberger I, Toledo-Sherman L, Toogood-Johnson I, Vaidya D, Winkler D, Wityak J., Yarnold CJ

Journal

J Med Chem

Year

2012

DOI

10.1021/jm201310y

PubMed

22224594

Machine-readable

REST APIRDF